99 related articles for article (PubMed ID: 12389623)
1. Filamentous fungi infection in patients with myelodysplastic syndrome. A report of twelve cases.
Mele L; Ricci P; Nosari A; Tonso A; Fianchi L; Cudillo L; Pagano L
Leuk Lymphoma; 2002 Jul; 43(7):1421-5. PubMed ID: 12389623
[TBL] [Abstract][Full Text] [Related]
2. Invasive fungal infection in patients with myelodysplastic syndrome: a report of twelve cases.
Mele L; Ricci P; Nosari A; Tonso A; Fianci L; Cudillo L; Pagano L
Leuk Lymphoma; 2002 Aug; 43(8):1613-7. PubMed ID: 12400604
[TBL] [Abstract][Full Text] [Related]
3. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
[TBL] [Abstract][Full Text] [Related]
4. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
5. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
Miguélez M; Lumbreras C; Herrero JA; Aguado JM; del Palacio A; Colina F; Gómez R; Lizasoain M; Moreno E; Rodríguez-Noriega A
Med Clin (Barc); 1998 Mar; 110(11):406-10. PubMed ID: 9608495
[TBL] [Abstract][Full Text] [Related]
6. A case of disseminated Trichosporon beigelii infection in a patient with myelodysplastic syndrome after chemotherapy.
Kim JC; Kim YS; Park CS; Kang JM; Kim BN; Woo JH; Ryu J; Kim WG
J Korean Med Sci; 2001 Aug; 16(4):505-8. PubMed ID: 11511798
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
8. Scedosporium inflatum infection in immunocompromised haematological patients.
Tapia M; Richard C; Baro J; Salesa R; Figols J; Zurbano F; Zubizarreta A
Br J Haematol; 1994 May; 87(1):212-4. PubMed ID: 7947251
[TBL] [Abstract][Full Text] [Related]
9. A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.
Rieger CT; Ostermann H; Kolb HJ; Fiegl M; Huppmann S; Morgenstern N; Tischer J
Ann Hematol; 2008 Nov; 87(11):915-22. PubMed ID: 18641986
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
11. The effect of current management on morbidity and mortality in hospitalised adults with funguria.
Simpson C; Blitz S; Shafran SD
J Infect; 2004 Oct; 49(3):248-52. PubMed ID: 15337343
[TBL] [Abstract][Full Text] [Related]
12. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
Selvy N; Villiet M; Hansel-Esteller S
Pathol Biol (Paris); 2010 Apr; 58(2):123-6. PubMed ID: 19864087
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
15. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
16. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
17. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
[TBL] [Abstract][Full Text] [Related]
18. Sinusitis caused by Exserohilum rostratum after cord blood transplantation for myelodysplastic syndrome: A case report and literature review.
Kohashi S; Toyama T; Hashimoto N; Sakurai M; Kato J; Kikuchi T; Koda Y; Sugita K; Hasegawa N; Yarita K; Kamei K; Okamoto S; Mori T
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29119669
[TBL] [Abstract][Full Text] [Related]
19. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
O'Donnell MR; Schmidt GM; Tegtmeier BR; Faucett C; Fahey JL; Ito J; Nademanee A; Niland J; Parker P; Smith EP
J Clin Oncol; 1994 Apr; 12(4):827-34. PubMed ID: 8151325
[TBL] [Abstract][Full Text] [Related]
20. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
